Treatment with anti-S8 also resulted in a significant reduction in lung fibrosis as assessed by Ashcroft score and decreased levels of collagen and TGFβ in BAL (Fig. 2i–k). This evidence concerns the gene TGFB1 and pulmonary fibrosis.